Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice
about
Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer?Modulation of APC Function and Anti-Tumor Immunity by Anti-Cancer DrugsImproving cancer immunotherapy by targeting the STATe of MDSCsThe interplay of immunotherapy and chemotherapy: harnessing potential synergiesChemoimmunotherapy.The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic markerEndometriosis-induced changes in regulatory T cells - insights towards developing permanent contraception.Therapeutic cancer vaccines: current status and moving forward.Whole cell vaccines--past progress and future strategies.The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitorsApicidin and docetaxel combination treatment drives CTCFL expression and HMGB1 release acting as potential antitumor immune response inducers in metastatic breast cancer cells.A pilot study of paclitaxel combined with gemcitabine followed by interleukin-2 and granulocyte macrophage colony-stimulating factor for patients with metastatic melanoma.The Basis of OncoimmunologyPreoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival.Harnessing the immune system for the treatment of breast cancer.GM-CSF-secreting vaccines for solid tumors: moving forward.Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy.Chemoimmunotherapy: reengineering tumor immunity.Immune modulation by chemotherapy or immunotherapy to enhance cancer vaccines.Potential approaches for more successful dendritic cell-based immunotherapy.Dendritic cell-based immunotherapy: a basic review and recent advances.Tubulin inhibitors in non-small cell lung cancer: looking back and forward.Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer.Restoring anti-oncodriver Th1 responses with dendritic cell vaccines in HER2/neu-positive breast cancer: progress and potential.Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent mannerOrigin and pharmacological modulation of tumor-associated regulatory dendritic cells.Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer.The role of TLR4 in the paclitaxel effects on neuronal growth in vitro.Conditioning neoadjuvant therapies for improved immunotherapy of cancer.Impact of chemotherapeutic agents on the immunostimulatory properties of human 6-sulfo LacNAc+ (slan) dendritic cells.Microneedle-Assisted, DC-Targeted Codelivery of pTRP-2 and Adjuvant of Paclitaxel for Transcutaneous Immunotherapy.
P2860
Q26747695-099A8AA6-87E8-4CAB-939F-D5C456FB5C9EQ26781522-13636215-BBC3-43CF-8924-496E80793996Q28066797-0BE82CEB-8BE2-4B86-BAE5-7C7ADA3B1C02Q28081893-C07E294A-6CD9-44B7-9A1D-58C4720FC900Q34058792-8DEE3985-F172-4CF2-AA02-C54B5E579EE6Q34380094-CA3E845B-166B-4DCF-8232-42BF09232471Q35864618-6BAB3534-3C11-4814-A20F-6CB9861E964FQ35894347-499686BD-F691-4F6C-BE68-0DD365E3DA65Q35975381-543E7375-4057-4105-9334-F26CF8854FAAQ35975387-A1585E0F-B083-4FC6-9607-9F3FBD419D50Q36282754-03373EA2-944B-4B20-876F-BA8A99D68D95Q36524227-200FEA73-0EFE-4472-AAC1-2456E52898F1Q36678851-E263CAEE-D28E-4603-93C4-79D34127023AQ36848102-453C5FCA-5A5A-4C1C-BAFF-F25C38DD7055Q37476039-A2A6C080-9B5A-4CC1-BD50-67B8B4A25ED5Q37776555-79C75514-CEA7-4AC0-B643-2C7BF4350115Q37969356-0610AD6C-D21E-4C23-A082-1A0720F02D3EQ38079749-4942B296-CCDD-4A90-B535-7F059E9470F8Q38161367-E1D4493B-7C0B-4AFF-BC1C-C7E70F0B27CFQ38305650-D18E350D-1F14-4A7F-9091-F7B682370656Q38665350-061F054E-1FC1-43DD-87F0-85484BC7909AQ38742506-B8DD34C4-3A8B-43D9-9BC9-4EDD601612D7Q38847914-32F30B9C-67A3-487C-85EA-CC1C3D1DAC6AQ38948901-65F0B4CB-1CA7-4B51-A1C7-B6B3ECB867D8Q39405279-8C0BC5A9-6790-4CE5-94DA-413E8C9F4C2BQ39858290-CFCDFB76-0E61-4828-B3A2-6A2CF3C26A63Q41897007-E318626F-0866-4C97-896A-85948E9B49FCQ43245268-986E0915-E1D3-41F7-B43B-29275C6DE3B8Q45065285-57DB2167-6C1A-4360-AF6C-452E28030720Q47241875-CD8F3409-EA12-4834-A13B-00E99E5F2615Q48351402-45CC0E47-923C-4E57-83B9-FA7EB8050F8D
P2860
Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Paclitaxel enhances early dend ...... through TLR4 signaling in mice
@ast
Paclitaxel enhances early dend ...... through TLR4 signaling in mice
@en
type
label
Paclitaxel enhances early dend ...... through TLR4 signaling in mice
@ast
Paclitaxel enhances early dend ...... through TLR4 signaling in mice
@en
prefLabel
Paclitaxel enhances early dend ...... through TLR4 signaling in mice
@ast
Paclitaxel enhances early dend ...... through TLR4 signaling in mice
@en
P2093
P2860
P1433
P1476
Paclitaxel enhances early dend ...... through TLR4 signaling in mice
@en
P2093
Leisha A Emens
Lukas W Pfannenstiel
Samuel S K Lam
Todd D Armstrong
P2860
P356
10.1016/J.CELLIMM.2010.03.001
P577
2010-03-06T00:00:00Z